Case number 1:25-cv-00301
Nevakar Injectables, Inc. et al v. Baxter Healthcare Corp. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jul 18, 2025 | N/A | SO ORDERED, re (171 in 1:21-cv-01184-CJB, 170 in 1:21-cv-01186-CJB, 16 in 1:25-cv-00301-CJB) Stipulation and Proposed Order to Consolidate C.A. No. 25-301-CJB into C.A. No. 21-1184-CJB and 21-1186-CJB filed by Long Grove Pharmaceuticals, LLC, Nevakar Injectables, Inc. Ordered by Judge Christopher J. Burke on 07/18/2025. Associated Cases: 1:21-cv-01184-CJB, 1:21-cv-01186-CJB, 1:25-cv-00301-CJB(sam) (Entered: 07/18/2025) (0) |
| Jul 18, 2025 | N/A | Case associated with lead case: CIVIL ACTION NO. 21-1184-CJB SHALL BE THE LEAD CASE AND ALL FUTURE FILINGS SHALL BE MADE IN THE LEAD CASE ONLY. Associated Cases: 1:21-cv-01186-CJB, 1:25-cv-00301-CJB(sam) (Entered: 07/18/2025) (0) |
| Jul 18, 2025 | 18 | NOTICE OF SERVICE of Baxter's Rule 26(a) Initial Disclosures filed by Baxter Healthcare Corporation, Baxter Healthcare Corp..(Rovner, Philip) (Entered: 07/18/2025) (2) |
| Jul 11, 2025 | 16 | Joint STIPULATION and [Proposed] Order to Consolidate C.A. No. 25-301-CJB into C.A. No. 21-1184-CJB and 21-1186-CJB by Long Grove Pharmaceuticals, LLC, Nevakar Injectables, Inc.. (Farnan, Kelly) (Entered: 07/11/2025) (3) |
| Jul 11, 2025 | 17 | Joint Letter to The Honorable Christopher J. Burke from Kelly E. Farnan and Philip A. Rovner regarding Proposed Scheduling Order. (Attachments: # 1 Proposed Scheduling Order)(Farnan, Kelly) (Entered: 07/11/2025) (0) |
| Jul 10, 2025 | N/A | SO ORDERED, D.I. 15 STIPULATION TO EXTEND TIME for the parties to submit a proposed schedule to July 11, 2025 filed by Baxter Healthcare Corp., Baxter Healthcare Corporation. Ordered by Judge Christopher J. Burke on 07/10/2025. (sam) (Entered: 07/11/2025) (0) |
| Jul 9, 2025 | 15 | STIPULATION TO EXTEND TIME for the parties to submit a proposed schedule to July 11, 2025 - filed by Baxter Healthcare Corporation, Baxter Healthcare Corp.. (Rovner, Philip) (Entered: 07/09/2025) (2) |
| Jun 26, 2025 | N/A | SO ORDERED, re (168 in 1:21-cv-01186-CJB, 169 in 1:21-cv-01184-CJB, 14 in 1:25-cv-00301-CJB) STIPULATION TO EXTEND TIME to submit proposed schedule to July 9, 2025 filed by Nevakar Injectables, Inc., Nevakar Injectables Inc. Ordered by Judge Christopher J. Burke on 06/26/2025. Associated Cases: 1:21-cv-01184-CJB, 1:21-cv-01186-CJB, 1:25-cv-00301-CJB(sam) (Entered: 06/26/2025) (0) |
| Jun 25, 2025 | 14 | STIPULATION TO EXTEND TIME to submit proposed schedule to July 9, 2025 - filed by Nevakar Injectables Inc., Nevakar Injectables, Inc.. (Metzler, Sara) (Entered: 06/25/2025) (2) |
| Jun 23, 2025 | N/A | SO ORDERED, re (167 in 1:21-cv-01186-CJB, 168 in 1:21-cv-01184-CJB, 13 in 1:25-cv-00301-CJB) STIPULATION TO EXTEND TIME to submit proposed schedule to June 25, 2025 filed by Nevakar Injectables, Inc., Nevakar Injectables Inc. Ordered by Judge Christopher J. Burke on 06/23/2025. Associated Cases: 1:21-cv-01184-CJB, 1:21-cv-01186-CJB, 1:25-cv-00301-CJB(sam) (Entered: 06/23/2025) (0) |
| Jun 18, 2025 | 13 | STIPULATION TO EXTEND TIME to submit proposed schedule to June 25, 2025 - filed by Nevakar Injectables Inc., Nevakar Injectables, Inc.. (Farnan, Kelly) (Entered: 06/18/2025) (2) |
| Jun 17, 2025 | 12 | ANSWER to 9 Answer to Complaint, Counterclaim by Long Grove Pharmaceuticals, LLC, Nevakar Injectables, Inc..(Farnan, Kelly) (Entered: 06/17/2025) (11) |
| May 28, 2025 | 11 | ORAL ORDER: IT IS HEREBY ORDERED that the parties shall meet and confer and discuss, in person and/or by telephone, each of the matters listed on Judge Burke's Case Management Checklist ("Checklist"). Within twenty-one (21) days from the date of this Order, the parties shall jointly file the following: (i) a copy of the Checklist, indicating the names of Lead Counsel and Delaware Counsel for each party; (ii) a proposed Scheduling Order, which is consistent with Judge Burke's "Rule 16 Scheduling Order - Patent"; and (iii) a letter, not to exceed three pages, that contains the following: (a) a description of what this case is about; (b) the parties' positions regarding any disputes in the proposed Scheduling Order, and (c) a list of the three most significant topics (other than Scheduling Order disputes) discussed during the parties' review of the Checklist items, along with a brief description as to what was discussed as to those topics. Thereafter, the Court may schedule a Case Management Conference/Rule 16 Scheduling Conference to be held with Judge Burke. The Checklist and Scheduling Order can be found on Judge Burke's portion of the District Court's website. Ordered by Judge Christopher J. Burke on 5/28/2025. (mlc) (Entered: 05/28/2025) (0) |
| May 27, 2025 | 9 | ANSWER to 1 Complaint, with Jury Demand , COUNTERCLAIM against Long Grove Pharmaceuticals, LLC, Nevakar Injectables, Inc. by Baxter Healthcare Corp.. (Attachments: # 1 Exhibit A)(Rovner, Philip) (Entered: 05/27/2025) (0) |
| May 27, 2025 | 10 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Baxter International, Inc. for Baxter Healthcare Corp. filed by Baxter Healthcare Corp.. (Rovner, Philip) (Entered: 05/27/2025) (1) |
| May 6, 2025 | 8 | CONSENT to Jurisdiction by U.S. Magistrate Judge filed by Baxter Healthcare Corp., Long Grove Pharmaceuticals, LLC, Nevakar Injectables, Inc.. Case reassigned to Magistrate Judge Christopher J. Burke. Signed by Judge Gregory B. Williams on 5/6/2025. (lnb) (Entered: 05/06/2025) (1) |
| May 6, 2025 | N/A | Remark: The parties should be aware that the Court encourages the participation of newer attorneys in courtroom proceedings and at oral argument. Please see the Court's Standing Order Regarding Courtroom Opportunities for Newer Attorneys, a link to which is provided here for the parties' convenience:http://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrder2017.pdf (sam) (Entered: 05/07/2025) (0) |
| May 6, 2025 | N/A | Remark: The parties should follow the Court's Standing Order Regarding Courtesy Copies, a copy of which is found on Judge Burke's portion of the District Court's webpage: https://www.ded.uscourts.gov/sites/ded/files/CJBCC2022.pdf (sam) (Entered: 05/07/2025) (0) |
| Apr 24, 2025 | 7 | ORAL ORDER: IT IS HEREBY ORDERED that, on or before May 5, 2025, the parties shall either (1) submit to the Clerk of Court an executed Form AO 85 Notice, Consent, and Reference of a Civil Action to a Magistrate Judge, indicating their consent to have a United States Magistrate Judge conduct all proceedings in this case including trial, the entry of final judgment, and post-trial proceedings; or (2) file a joint letter indicating that all the parties do not consent to a referral of this action to a Magistrate Judge. The letter should not indicate which party or parties did not consent to the referral of this action to a Magistrate Judge. If all parties consent, this action will be referred to Magistrate Judge Christopher J. Burke, given that Magistrate Judge Burke is already handling Civil Action No. 21-1184 and Civil Action No. 21-1186 between these same parties by consent. ORDERED by Judge Gregory B. Williams on 4/24/2025. (lnb) (Entered: 04/24/2025) (0) |
| Mar 19, 2025 | N/A | Case Assigned to Judge Gregory B. Williams. Please include the initials of the Judge (GBW) after the case number on all documents filed. (rjb) (Entered: 03/19/2025) (0) |
| Mar 12, 2025 | 6 | Summons Issued as to Baxter Healthcare Corp. on 3/12/2025. (jfm) (Entered: 03/12/2025) (2) |
| Mar 11, 2025 | 1 | Complaint* (1) |
| Mar 11, 2025 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 03/12/2025) (3) |
| Mar 11, 2025 | 3 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 12,245,996. (jfm) (Entered: 03/12/2025) (1) |
| Mar 11, 2025 | 4 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Nevakar, Inc. for Nevakar Injectables, Inc. - filed by Nevakar Injectables, Inc. (jfm) (Entered: 03/12/2025) (1) |
| Mar 11, 2025 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Long Grove Pharmaceuticals Holdings, LLC for Long Grove Pharmaceuticals, LLC - filed by Long Grove Pharmaceuticals, LLC. (jfm) (Entered: 03/12/2025) (1) |
